Latest News
21-Jan-2025 Indian Drugmakers Likely to Gain Under the New US Govt
17-Jan-2025 Halt Illegal Imports of Refurbished Medical Gear: Drug Regulator
13-Jan-2025 Pharma Lobby Seeks 2-year Extension of Schedule M Deadline
07-Jan-2025 Biosimilar Brand Buy to Help Intas Take on Biggies
07-Jan-2025 Biosimilar Brand Buy to Help Intas Take on Biggies
  more...
Latest Reports
Jan-25 March of corporate hospitals: Deepening presence - Emkay Research  
Jan-25 US pricing pressure eases; margins improve - Nirmal Bang  
Jan-25 Chemicals/Pharma EXIM trends - Phillip Capital  
Jan-25 3QFY25 Preview: Change in script unlikely - Emkay Research  
Jan-25 Bed additions/ARPOB to drive growth during the quarter - Centrum Research  
  more...

Quarterly Summary September-2024
Desc Current Previous Per.Chg
Sales 67242.7 61013.1 10.2
Otherincome 2488.6 2287.7 8.8
Expense 49904.7 47193.7 5.7
RawMaterial 19003.4 18996.8 0.0
StaffCost 9916.5 9105.9 8.9
ExciseDuty 78.8 58.9 33.9
OtherExp 15371.3 14258.0 7.8
Interest 1058.2 1028.8 2.9
GrossProfit 20070.8 16023.1 25.3
Depreciation 2672.0 2717.1 -1.7
Tax 4076.5 2892.1 41.0
NetProfit 13339.3 10504.1 27.0
Total.Comp 176 -- --
Source: ETIG Database

Sectoral Companies As on 21 Jan 2025
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 422708.67
Divi's Lab 154449.43
Cipla 115268.75
Dr.Reddy's 107508.27
Torrent Phar 106865.81
Mankind Phar 105763.82
Zydus Life 99186.17
Lupin 95967.63
Aurobindo Ph 69528.75
Alkem Labora 61874.90
Abbott (I) 58735.00
Glenmark Pha 42324.36
IPCA Lab. 39157.33
  click here for the complete list